Biomarkers in malignant pleural mesothelioma: current status and future directions

被引：16
作者：
Ahmadzada, Tamkin [1 ]
Reid, Glen [1 ,2 ]
Kao, Steven [2 ,3 ]
机构：
[1] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[2] ADRI, Sydney, NSW, Australia
[3] Chris OBrien Lifehouse, Dept Med Oncol, Sydney, NSW, Australia
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷
关键词：
DETECT ASBESTOS EXPOSURE; OPEN-LABEL; DIAGNOSIS; PROGNOSIS; TRIAL; OSTEOPONTIN; EXPRESSION; FIBULIN-3; HMGB1;
D O I：
10.21037/jtd.2018.04.31
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：S1003 / S1007
页数：5
相关论文
共 50 条
  • [21] Current Management and Future Perspective in Pleural Mesothelioma
    Shah, Rajiv
    Klotz, Laura V.
    Glade, Julia
    CANCERS, 2022, 14 (04)
  • [22] MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions
    Birnie, Kimberly A.
    Prele, Cecilia M.
    Musk, Arthur W.
    de Klerk, Nicholas
    Lee, Y. C. Gary
    Fitzgerald, Deirdre
    Allcock, Richard J. N.
    Thompson, Philip J.
    Creaney, Jenette
    Badrian, Bahareh
    Mutsaers, Steven E.
    DISEASE MARKERS, 2019, 2019
  • [23] Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment
    Gounant, Valerie
    Brosseau, Solenn
    Zalcman, Gerard
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [24] Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome
    Lacerenza, Serena
    Ciregia, Federica
    Giusti, Laura
    Bonotti, Alessandra
    Greco, Viviana
    Giannaccini, Gino
    D'Antongiovanni, Vanessa
    Fallahi, Poupak
    Pieroni, Luisa
    Cristaudo, Alfonso
    Lucacchini, Antonio
    Mazzoni, Maria Rosa
    Foddis, Rudy
    CANCER GENOMICS & PROTEOMICS, 2020, 17 (03) : 225 - 236
  • [25] Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma
    Liu, Hui
    Wu, Licun
    Ji, Kai
    Wang, Wei
    TUMOR BIOLOGY, 2015, 36 (10) : 7375 - 7384
  • [26] Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma
    Strbac, Danijela
    Goricar, Katja
    Dolzan, Vita
    Kovac, Viljem
    DISEASE MARKERS, 2017, 2017
  • [27] Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation
    Vogl, Melanie
    Rosenmayr, Anna
    Bohanes, Tomas
    Scheed, Axel
    Brndiar, Milos
    Stubenberger, Elisabeth
    Ghanim, Bahil
    CANCERS, 2021, 13 (04) : 1 - 24
  • [28] Biomarkers in Hepatocellular Carcinoma: Current Status and Future Perspectives
    Pan, Yasi
    Chen, Huarong
    Yu, Jun
    BIOMEDICINES, 2020, 8 (12) : 1 - 17
  • [29] Malignant pleural mesothelioma
    Chen, Sheree E.
    Pace, Makala B.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (05) : 377 - 385
  • [30] Malignant pleural mesothelioma
    Margery, J.
    Planchard, D.
    ONCOLOGIE, 2014, 16 (05) : 245 - 249
12345